Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
ATDC
gene was originally identified by its ability to complement the radiosensitivity defect of an ataxia telangiectasia (AT) fibroblast cell line. Because hypersensitivity to ionizing radiation is an important feature of the AT phenotype, we reasoned that
ATDC
may function generally in the suppression of radiosensitivity. Previous work in our laboratory focused on radiosensitization mechanisms in human squamous carcinoma (SC) cells, especially A431 cells. To establish a basis for investigating the role of
ATDC
in radiation-responsive signaling pathways in human SC cells, we characterized
ATDC
message and protein expressions in A431 cells.
ATDC
message expression was also compared among human epidermoid cells (A431 cells, HaCaT spontaneously immortalized human keratinocytes and normal human epidermal keratinocytes) and a normal human fibroblast cell line (LM217). We made the following major observations: (i) the relative abundance of
ATDC
message is substantially higher in the epidermoid cells than in the fibroblast cell line, which has a message level comparable to those reported for other fibroblast lines; (ii)
ATDC
is constitutively phosphorylated on serine/threonine in A431 cells; (iii) in A431 cells,
ATDC
is a substrate for the serine/threonine protein kinase C (PKC) but not the
epidermal growth factor (EGF) receptor
tyrosine kinase; and (iv) EGF decreases
ATDC
message and protein expressions in A431 cells after a 24-hr exposure. The phosphorylation studies suggest that the ability of
ATDC
to modulate cellular radiosensitivity may be mediated in part through a PKC signaling pathway.
...
PMID:Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells. 864 48